Related references
Note: Only part of the references are listed.Locoregional Spread of Cutaneous Melanoma: Sonography Findings
Orlando Catalano et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients
Charles R. Scoggins et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tuomas Tammela et al.
CELL (2010)
Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data
Yoichi Moroi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2009)
Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma
Merlin M. Guggenheim et al.
ANNALS OF SURGERY (2008)
Commentary on in-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure
Gabor Cserni
JOURNAL OF CLINICAL PATHOLOGY (2008)
Non-Sentinel Lymph Node Metastases Associated With Isolated Breast Cancer Cells in the Sentinel Node
Carolien H. M. van Deurzen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer
Jeremy B. Burton et al.
NATURE MEDICINE (2008)
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation
Tuomas Tammela et al.
NATURE MEDICINE (2007)
Functionally specialized junctions between endothelial cells of lymphatic vessels
Peter Baluk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications.
Tohru Hoshida et al.
CANCER RESEARCH (2006)
Inhibtion of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2
N Roberts et al.
CANCER RESEARCH (2006)
Laser-mediated photodynamic therapy
M Alexiades-Armenakas
CLINICS IN DERMATOLOGY (2006)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Tumor β-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis
WS Chen et al.
CLINICAL CANCER RESEARCH (2005)
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor
JM Lin et al.
CANCER RESEARCH (2005)
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
T Tammela et al.
BLOOD (2005)
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels
YL He et al.
CANCER RESEARCH (2005)
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
P Baluk et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis
TV Petrova et al.
NATURE MEDICINE (2004)
An evidence-based staging system for cutaneous melanoma
CM Balch et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes
U Schlötzer-Schrehardt et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2002)
Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo
TV Byzova et al.
BLOOD (2002)
Lymphatic metastasis in the absence of functional intratumor lymphatics
TP Padera et al.
SCIENCE (2002)
Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages
E Kriehuber et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin
B Enholm et al.
CIRCULATION RESEARCH (2001)
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
T Veikkola et al.
EMBO JOURNAL (2001)
Share Paper
